male  doctor carefully holding the ear of his patient to establish a clearer view of the inside of his ear

Over 45 Years of Research

The RVEEH Research Foundation was founded in 1972, as an independent institution and registered charity. It works closely with the hospital to foster primary research, both clinical and laboratory based and is essential to attract high quality medical professionals and to promote the international medical reputation of the hospital.

Ophthalmology research at the Royal Victoria Eye and Ear Hospital benefits from strong collaborations with other research groups at the Royal College of Surgeons in Ireland, Dublin City University and Trinity College Dublin. There is an emphasis on clinical and translational research, where patient-focused laboratory investigations aim to improve patient care through the development of new treatments.

Target 5000

The Inherited Retinal Disease service at the RVEEH is a strategically important quaternary service for the hospital. The genetic research team have identified almost 3,000 inherited retinal disease patients, and when identified, suitable patients are invited to be part of the Target 5000 project, a project that provides a genetic and clinical diagnosis for people with Inherited Retinal Degeneration (IRD).

The hospital is the primary site for the Target 5000 project which is supported by Fighting Blindness. The initiative is also developing a national registry for IRD and enables access to clinical trials and approved therapies for Irish patients. Target 5000 emerged from a longstanding collaboration with the Research Foundation and the Ocular Genetics Department of Trinity College Dublin and started in the 1980s. The Mater Misericordiae University Hospital and the Royal Victoria Hospital Belfast are also project sites that aim to provide genetic testing for 5,000 Irish people who have an inherited retinal condition.

Genetic testing

The hospital is the primary site for the Target 5000 project

Support Our Research

donate to AFI
We'd love to keep you informed about our exciting work


Please download and fill out our Opt-In Form then email it back to us at